Does Rifampin Reduce Tigecycline's Potency?
Yes, rifampin reduces tigecycline's potency by inducing its metabolism, leading to lower tigecycline blood levels and potentially decreased effectiveness against infections.[1][2]
Tigecycline, a glycylcycline antibiotic used for complicated skin/skin structure infections, intra-abdominal infections, and resistant bugs like MRSA or Acinetobacter, is primarily cleared via biliary excretion but undergoes some hepatic metabolism via CYP3A4. Rifampin, a potent CYP3A4 inducer, accelerates this process, dropping tigecycline's area under the curve (AUC) by about 25-30% in pharmacokinetic studies.[1][3]
How Strong Is the Interaction?
Clinical data from healthy volunteer trials show rifampin (600 mg daily) lowers tigecycline's maximum concentration (Cmax) by ~20% and AUC by ~25-33%, depending on tigecycline dose (25-100 mg).[1][2] This isn't as drastic as some interactions (e.g., rifampin cuts oral contraceptives by 40-50%), but it can matter for severe infections where tigecycline levels need to stay high to fight biofilms or intracellular pathogens.[4]
No large infection-treatment trials directly compare tigecycline alone vs. with rifampin, but the FDA label warns of reduced efficacy and advises against co-administration unless benefits outweigh risks, with monitoring or dose adjustments.[1]
When Does This Matter Most?
The drop hits hardest in prolonged therapy for deep-seated infections like ventilator-associated pneumonia or osteomyelitis, where tigecycline's already modest efficacy (cure rates ~70-80% in trials) could slip further.[5] In short courses or mild cases, it might not tip the scales. Patient factors like liver function amplify the issue—impaired hepatic clearance worsens the relative drop.[2]
Alternatives If Using Both Drugs
- Avoid combo: Guidelines (IDSA, others) favor separating them by time or picking non-interacting options.[6]
- Switch rifampin: Use moxifloxacin or linezolid for TB/MRSA if tigecycline is key.
- Tigecycline tweaks: Higher loading doses (200 mg) or extended infusions might compensate, per PK modeling, but unproven clinically.[3]
- Monitor levels: Therapeutic drug monitoring for tigecycline is emerging in ICU settings.[7]
Related Drug Interactions With Tigecycline
Rifampin isn't alone—CYP3A4 inducers like carbamazepine or phenytoin cause similar ~20-30% drops.[1] Inhibitors (ketoconazole) boost levels by 20-40%, risking toxicity like nausea or pancreatitis.[2] Warfarin users see altered INR with tigecycline alone, unrelated to rifampin.[1]
[1]: FDA Tigecycline Label
[2]: Drug Interactions Database - Lexicomp
[3]: Clinical Pharmacokinetics Study - Antimicrob Agents Chemother 2009
[4]: Rifampin PK Overview - Clin Pharmacokinet 2005
[5]: Tigecycline Trials Meta-Analysis - Lancet Infect Dis 2014
[6]: IDSA Skin Infection Guidelines 2014
[7]: TDM Review - J Antimicrob Chemother 2020